Search Within

Jacob Drobnyk Soumerai

Formats
  1. Meeting Abstract (12)
  2. Journal Article (7)
Groups
  1. Center for Hematologic Malignancies (18)
  2. Department of Medicine (18)
  3. Hematologic Malignancies, Division of (18)
  4. Lymphoma (18)
  5. Biostatistics Service (14)
  6. Epidemiology and Biostatistics (14)

More Groups

People
  1. Andrew Zelenetz (18)
  2. Ai Ni (12)
  3. Anas Younes (10)
  4. Anna Alperovich (8)
  5. Connie Batlevi (8)
  6. Alison Moskowitz (7)

More People

Years
  1. 2022 (1)
  2. 2020 (2)
  3. 2019 (2)
  4. 2018 (2)
  5. 2017 (6)
  6. 2016 (5)

More Years

Publications
  1. Blood (6)
  2. Hematological Oncology (3)
  3. Leukemia and Lymphoma (3)
  4. American Journal of Hematology (1)
  5. Blood Cancer Journal (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Taylor & Francis Group (3)
  3. Wiley Blackwell (3)
  4. American Association for Cancer Research (1)
  5. American Society of Clinical Oncology (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma
    Journal Article

    Fischer, T.; Ni, A.; Bantilan, K. S.; Soumerai, J. D.; Alperovich, A.; Batlevi, C.; Younes, A.; Zelenetz, A. D.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Journal Article

    Soumerai, J. D.; Ni, A.; Alperovich, A.; Batlevi, C.; Bantilan, K. S.; Fischer, T.; Copeland, A. R.; Smith, K.; Ying, Z.; Younes, A.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials
    Journal Article

    Soumerai, J. D.; Ni, A.; Xing, G.; Huang, J.; Furman, R. R.; Jones, J.; Sharman, J. P.; Hallek, M.; Adewoye, A. H.; Dubowy, R.; more...
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: A retrospective, pooled cohort study with external validations
    Journal Article

    Soumerai, J. D.; Ni, A.; Darif, M.; Londhe, A.; Xing, G.; Mun, Y.; Kay, N. E.; Shanafelt, T. D.; Rabe, K. G.; Byrd, J. C.; more...
    The Lancet Haematology (2019)

    Fulltext@MSK | Save
  • Risk model for overall survival for patients with relapsed/refractory chronic lymphocytic leukemia: Validated for patients on ibrutinib, idelalisib, venetoclax, or chemoimmuniotheraphy
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Darif, M.; Londhe, A.; Xing, G.; Mun, Y.; Kay, N. E.; Shanafelt, T. D.; Chaffee, K. G.; Furman, R. R.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukaemia applicable to patients treated with novel therapies and standard of care
    Meeting Abstract

    Hillmen, P.; Soumerai, J.; Zelenetz, A.; Darif, M.; Londhe, A.; Xing, G.; Huang, J.; Lin, M.; Byrd, J.; Chanan-Khan, A.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukemia applicable to patients treated with novel therapies and standard of care
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Darif, M.; Londhe, A.; Xing, G.; Huang, J.; Lin, M.; Byrd, J. C.; Chanan-Khan, A. A.; Furman, R. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Natural history of hypogammaglobulinemia in patients with follicular lymphoma and the impact of anti-CD20-based therapy
    Meeting Abstract

    Fischer, T.; Ni, A.; Soumerai, J. D.; Alperovich, A.; Batlevi, C. L.; Younes, A.; Zelenetz, A. D.
    Blood (2017)

    Fulltext@MSK | Save
  • The PARP inhibitor veliparib can be safely added to bendamustine and rituximab and has preliminary evidence of activity in B-cell lymphoma
    Journal Article

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Straus, D. J.; Moskowitz, A. J.; Younes, A.; Matasar, M. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save